NASDAQ:ALEC Alector (ALEC) Stock Price, News & Analysis $2.34 +0.04 (+1.74%) Closing price 04:00 PM EasternExtended Trading$2.34 0.00 (-0.21%) As of 04:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Alector Stock (NASDAQ:ALEC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Alector alerts:Sign Up Key Stats Today's Range$2.27▼$2.4850-Day Range$1.81▼$2.6352-Week Range$1.09▼$2.84Volume1.95 million shsAverage Volume1.58 million shsMarket Capitalization$348.38 millionP/E Ratio6.69Dividend YieldN/APrice Target$5.10Consensus RatingHold Company Overview Alector, Inc. is a biotechnology company based in South San Francisco, California, that develops investigational therapies for neurodegenerative diseases. Its research focuses on the role of the immune system in the brain and how immune pathways may be used to address disease processes. The company’s approach draws on human genetics and immunology to identify potential therapeutic targets. Its research has included programs targeting progranulin and TREM2, proteins associated with brain health and neurodegenerative disease. Alector’s work has centered on antibody-based drug candidates and clinical development rather than marketed medicines. The company has no approved products; its investigational programs are intended to address conditions such as frontotemporal dementia and other neurodegenerative disorders.AI Generated. May Contain Errors. Read More Alector Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks91st Percentile Overall ScoreALEC MarketRank™: 4.541284403665 of 5 starsAlector scored higher than 91% of companies evaluated by MarketBeat, and ranked 19th out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.2 / 5Analyst RatingHold Consensus RatingAlector has received a consensus rating of Hold. The company's average rating score is 2.43, and is based on 1 strong buy rating, 3 buy ratings, 1 hold rating, and 2 sell ratings.Upside PotentialAlector has a consensus price target of $5.10, representing about 116.6% upside from its current price of $2.36.Amount of Analyst CoverageAlector has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Alector's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Alector are expected to decrease in the coming year, from $0.48 to ($0.67) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Alector is 6.73, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.47.Price to Earnings Ratio vs. SectorThe P/E ratio of Alector is 6.73, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 32.68.Price to Earnings Growth RatioAlector has a PEG Ratio of 0.16. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioAlector has a P/B Ratio of 3.02. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted8.20% of the float of Alector has been sold short.Short Interest Ratio / Days to CoverAlector has a short interest ratio ("days to cover") of 3.62, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Alector has recently decreased by 18.15%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAlector does not currently pay a dividend.Dividend GrowthAlector does not have a long track record of dividend growth. News and Social Media3.0 / 5News Sentiment0.75 News SentimentAlector has a news sentiment score of 0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Alector this week, compared to 4 articles on an average week.Search Interest4 people have searched for ALEC on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Alector to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Alector insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $295,633.00 in company stock.Percentage Held by Insiders8.30% of the stock of Alector is held by insiders.Percentage Held by Institutions85.83% of the stock of Alector is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Alector's insider trading history. Receive ALEC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alector and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ALEC Stock News HeadlinesAlector (ALEC) Stock Sees Fair Value Lift As Analysts Split On Genentech DealNovember 16, 2026 | finance.yahoo.comAlector (NASDAQ:ALEC) Research Coverage Started at Wells Fargo & CompanyNovember 16, 2026 | americanbankingnews.comI'm handing you this stock todayElon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public company. Now he's planning 1,000,000 AI satellites in orbit, and every one could pay this company a royalty. Analyst Dylan says the window to get in closes around December 8th, before new money floods into the buildout.November 20 at 1:00 AM | Behind the Markets (Ad)Certain Restricted Stock Units of Alector, Inc. are subject to a Lock-Up Agreement Ending on 16-NOV-2026.November 15, 2026 | marketscreener.comMCertain Common Stock of Alector, Inc. are subject to a Lock-Up Agreement Ending on 16-NOV-2026.November 15, 2026 | marketscreener.comMEarnings Estimates Rising for Alector (ALEC): Will It Gain?November 11, 2026 | finance.yahoo.comAlector (NASDAQ:ALEC) Research Coverage Started at HC WainwrightNovember 9, 2026 | americanbankingnews.comAlector, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026November 6, 2026 | marketscreener.comMSee More Headlines ALEC Stock Analysis - Frequently Asked Questions How have ALEC shares performed this year? Alector's stock was trading at $1.56 at the start of the year. Since then, ALEC shares have increased by 51.0% and is now trading at $2.3550. How were Alector's earnings last quarter? Alector, Inc. (NASDAQ:ALEC) issued its earnings results on Thursday, November, 5th. The company reported $1.11 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.23) by $1.34. The company earned $162.87 million during the quarter, compared to analysts' expectations of $2.19 million. Alector had a net margin of 23.87% and a trailing twelve-month return on equity of 112.21%. Does Alector have any subsidiaries? Alector subsidiaries include these companies: Alector LLC. When did Alector IPO? Alector (ALEC) raised $176 million in an initial public offering on Thursday, February 7th 2019. The company issued 9,250,000 shares at $18.00-$20.00 per share. Morgan Stanley, BofA Merrill Lynch, Cowen and Barclays acted as the underwriters for the IPO. Who are Alector's major shareholders? Alector's top institutional investors include State Street Corp (1.64%), Marshall Wace LLP (0.65%), Goldman Sachs Group Inc. (0.53%) and Utah Retirement Systems (0.12%). Insiders that own company stock include Arnon Rosenthal, Sara Kenkare-Mitra, Neil Lindsay Berkley, Marc Grasso, Gary Romano, Grace Wong-Sarad, Kristine Yaffe and Paula Hammond. View institutional ownership trends. How do I buy shares of Alector? Shares of ALEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Alector own? Based on aggregate information from My MarketBeat watchlists, some other companies that Alector investors own include Editas Medicine (EDIT), Advanced Micro Devices (AMD), CRISPR Therapeutics (CRSP), Gossamer Bio (GOSS), Aktis Oncology (AKTS), Precision BioSciences (DTIL) and NVIDIA (NVDA). Company Calendar Last Earnings11/05/2026Today11/20/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 ALEC's financial health is in the Green zone, according to TradeSmith. ALEC has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:ALEC CIK1653087 Webwww.alector.com Phone(415) 231-5660FaxN/AEmployees103Year Founded2013Price Target and Rating Average Price Target for Alector$5.10 High Price Target$8.00 Low Price Target$1.50 Potential Upside/Downside+117.9%Consensus RatingHold Rating Score (0-4)2.43 Research Coverage7 Analysts Profitability EPS (Trailing Twelve Months)$0.35 Trailing P/E Ratio6.69 Forward P/E RatioN/A P/E Growth0.16Net Income-$142.93 million Net Margins23.87% Pretax Margin24.08% Return on Equity112.21% Return on Assets18.37% Debt Debt-to-Equity RatioN/A Current Ratio4.10 Quick Ratio4.10 Sales & Book Value Annual Sales$21.05 million Price / Sales16.55 Cash FlowN/A Price / Cash FlowN/A Book Value$0.78 per share Price / Book3.00Miscellaneous Outstanding Shares148,880,000Free Float136,520,000Market Cap$348.38 million OptionableOptionable Beta0.61 Social Links The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:ALEC) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredWorse than socialismDonald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same ec...Porter & Company | SponsoredYour father's savings lost half their value after 1971.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alector, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alector With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.